ESTECH Launches AFfirm(TM), First Cardiac Surgery Product Indicated for Use in the Treatment of Atrial Fibrillation
Posted on: Thursday, 1 June 2006, 06:00 CDT
ESTECH announced today market launch of AFfirm(TM), an Atrial Fibrillation (AF) conduction block verification probe and the latest product innovation in ESTECH's drive to set a new standard in Atrial Fibrillation treatments.
AFfirm is the first cardiac surgery product approved for use in the treatment of Atrial Fibrillation, a serious heart disease affecting over five million people in the U.S. and Europe. AFfirm offers a powerful tool in Cardiac Ablation Treatment, a procedure using Radio Frequency energy to block abnormal electrical pathways in the heart. AFfirm assesses the effectiveness of these treatments, which create new electrical paths in the heart, resulting in improved cure rates. AFfirm's flexible design allows easy access to treatment sites, including minimally invasive or "stand alone" treatments for AF.
"This probe is exactly what we need -- a simple tool to verify the quality and effectiveness of our treatments. The bipolar component of the design gives the surgeon a more precise indication of treatment success," said Mathew Williams, M.D., Columbia University Medical Center, New York.
ESTECH's COBRA(R) technology uses a patented, intelligent temperature-based system that provides both optimal and reproducible results by regulating the Radio Frequency (RF) energy. The COBRA Adhere(TM) and Adhere XL(TM) are used by surgeons to block the electrical impulses that cause AF, which is a heart disease associated with serious complications and is the leading cause of stroke.
David Swanson, Ph.D., ESTECH Chief Technical Officer, stated, "The AFfirm pacing probe provides a convenient and reliable means for the surgeon to confirm the cardiac ablation procedure was successful. With the ESTECH approach, treatment success is evaluated based on conduction block, the gold standard used in electrophysiologic testing. We believe our approach to assessing cardiac ablation success is a far superior method to techniques used by other companies. AFfirm provides reliable confirmation surgeons can depend on, leading to improved patient cure rates, the goal of AF treatment."
About ESTECH
Headquartered in San Ramon, CA, ESTECH offers tools for least invasive techniques and traditional approaches to the procedures cardiac surgeons do every day -- coronary artery bypass, valve surgery, ablation and surgical treatment of congestive heart failure.
Source: Business Wire
Related Articles
- Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations
- Blue Cross Blue Shield of Michigan Plans to Offer Customer Groups Ability to Purchase Coverage of Autism Treatment Programs that Provide Intensive Early Intervention
- APC Provides Electrical Efficiency Data on the Web for Its Enterprise Products to Enhance Product Selection Process
- FuelCell Energy Sells DFC Power Plant to Provide Electricity for New Warehouse Facility; Thermal Energy From Ultra-Clean Power Plant Will Heat New 400,000 Square Foot Temperature and Humidity-Controlled Storage Facility
- Surface Logix Says Heart Treatment is Well Tolerated
- NeurogesX Extension Study Indicates Repeat Treatment With Transacin Provides Prolonged Pain Reduction in HIV-Associated Neuropathy; Company Initiates Confirmatory Pivotal Phase 3 Study in Painful HIV-Associated Neuropathy
- Virginia Sales Tax Treatment of Electronically Provided Software
- Alcoa Looking to Buy a Power Plant to Provide Electricity for Its Aluminum Smelting Plant in MD
- ImClone Systems Launches First-of-Its-Kind Registry for Head and Neck Cancer Patients at ASTRO Annual Meeting; ''LORHAN'' Registry to Enrich Treatment Practice By Providing Insight into National Treatment Trends and Outcomes
- Powerful Lure Draws N. Korea Back to Talks; S. Korea to Provide Electricity to North
 |
 |
User Comments (0)
RSS Feeds